| Literature DB >> 35269561 |
Eugenia Z Poh1,2,3,4, Courtney Green2, Luca Agostinelli2, Marissa Penrose-Menz1, Ann-Kathrin Karl1,5, Alan R Harvey2,3, Jennifer Rodger1,3.
Abstract
Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain stimulation technique that has the potential to treat a variety of neurologic and psychiatric disorders. The extent of rTMS-induced neuroplasticity may be dependent on a subject's brain state at the time of stimulation. Chronic low intensity rTMS (LI-rTMS) has previously been shown to induce beneficial structural and functional reorganisation within the abnormal visual circuits of ephrin-A2A5-/- mice in ambient lighting. Here, we administered chronic LI-rTMS in adult ephrin-A2A5-/- mice either in a dark environment or concurrently with voluntary locomotion. One day after the last stimulation session, optokinetic responses were assessed and fluorescent tracers were injected to map corticotectal and geniculocortical projections. We found that LI-rTMS in either treatment condition refined the geniculocortical map. Corticotectal projections were improved in locomotion+LI-rTMS subjects, but not in dark + LI-rTMS and sham groups. Visuomotor behaviour was not improved in any condition. Our results suggest that the beneficial reorganisation of abnormal visual circuits by rTMS can be significantly influenced by simultaneous, ambient visual input and is enhanced by concomitant physical exercise. Furthermore, the observed pathway-specific effects suggest that regional molecular changes and/or the relative proximity of terminals to the induced electric fields influence the outcomes of LI-rTMS on abnormal circuitry.Entities:
Keywords: LI-rTMS; brain state; locomotion; neuroplasticity; topography; visual activity; visual pathways
Mesh:
Substances:
Year: 2022 PMID: 35269561 PMCID: PMC8910719 DOI: 10.3390/ijms23052418
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Number of successful layer 5 V1 injections and labelled corticotectal TZs in ephrin-A2A5-/- mice. Two colours refer to the successful labelling of TZs following medial Alexa Fluor 555 and lateral Alexa Fluor 488 injections.
| Dark | Locomotion | ||||
|---|---|---|---|---|---|
| Sham | LI-rTMS | Sham | LI-rTMS | ||
| No. of successful | One | 8 | 8 | 6 | 6 |
| Two | 2 | 2 | 3 | 3 | |
| Total no. of injections | 12 | 12 | 12 | 12 | |
| No. of TZs per | =1 | 4 | 8 | 9 | 8 |
| >1 | 8 (67%) | 4 (33%) | 3 (25%) | 4 (33%) | |
Figure 1Linear regression analyses of injection and TZ location in ephrin-A2A5-/- mice following chronic LI-rTMS. Sham or LI-rTMS was delivered to adult ephrin-A2A5-/- mice for 14 consecutive days in a red-light room (dark) or with free access to a running wheel (locomotion). Example image of (A) injection site in V1 (scale bar = 250 µm) and (B) anterograde TZ labelling in the stratum griseum superficiale (SGS) in the SC (scale bar = 100 µm). (C) The location of fluorescent injections in V1 was expressed as a percentage of the lateromedial axis (L-M) of the hemisphere width, and TZ location was expressed as a percentage of the rostrocaudal axis (R-C) of the whole length of the SC. The coefficient of determination of the linear relationship between injection site in V1 and TZ location in the SC is presented. ** p < 0.01, linear regression analysis.
Figure 2Geniculocortical neuron labelling of adult ephrin-A2A5-/- mice following chronic LI-rTMS in a dark environment. Injections of fluorescent dye into V1 retrogradely labelled dLGN neurons. (Ai) Example image of disperse labelling in dark-sham-treated ephrin-A2A5-/- mice, whereas (Aii) dark-LI-rTMS-treated mice exhibited less dispersion (scale bar = 100 µm). (B) Example image of dLGN identified in a cresyl-stained section (scale bar = 250 µm). (C) The average number of labelled dLGN neurons were not different between treatment (sham vs. LI-rTMS) and environment (dark vs. locomotion) groups. (D) The total dispersion volume of dLGN neurons was reduced by chronic online LI-rTMS. Interestingly, locomotion groups also had less overall dispersion volume as compared to subjects in the dark group. (E) Main cluster areas were not altered by LI-rTMS. However, locomotion groups had larger areas as compared to dark animals. Error bars represent SEM. Uppermost lines denote univariate analysis (* p < 0.05) and angled lines denote follow-up pairwise comparisons with Sidak correction (* p < 0.05, *** p < 0.001).
Figure 3Online LI-rTMS did not alter the total distance ran during each session and over all sessions. Adult ephrin-A2A5-/- mice were given free access to a running wheel during each treatment session. (A) Average revolutions on the running wheel per day were not different between sham or LI-rTMS treated subjects. Error bars represent SEM. (B) Cumulative number of running wheel revolutions over the 14 days.
Figure 4Experimental timeline of the current study. Adult ephrin-A2A5-/- mice were divided into two environmental conditions. In Experiment 1, the mice were able to freely move in a dark environment and in Experiment 2, they were given free access to a running wheel in ambient light. In both experiments, the mice received either LI-rTMS or sham for 14 daily 10 min sessions.